ArticleDiabetes, obesity & metabolism2026

Correction to "Serum IGF-1 and the Risk of Cardio-Kidney Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.